| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
13.07.2022 US 202217812299
13.07.2022 US 202263388720 P
|
| (71) |
Applicant: GlaxoSmithKline Intellectual Property (No.3)
Limited |
|
Stevenage SG1 2NY (GB) |
|
| (72) |
Inventors: |
|
- HALL, David
Stevenage Hertfordshire SG1 2NY (GB)
- PRESTON, Alexander
Stevenage Hertfordshire SG1 2NY (GB)
- MACPHEE, Colin
Collegeville, Pennsylvania 19426 (US)
|
| (74) |
Representative: Goddard, Carolyn Janice |
|
GSK
Legal & Compliance - Global Patents
79 New Oxford Street
London WC1A 1DG
London WC1A 1DG (GB) |
|
